AGP Picks View all

Health Wire Taiwan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.

Press releases published on September 8, 2026

CyberSigna Introduces Enterprise AI Trust and Intelligence Platform
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
Tria Federal Joins Appian Public Sector Partner Program to Power Federal Missions
Vivos Therapeutics Announces Material Debt Reduction
NeOnc' Phase 2 Data Could Put Cancer on the Ropes
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
Bone Biologics Expands Trial Sites
Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Wire Taiwan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.